{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:33:26Z","timestamp":1788798806479,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["lrjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.leukres.2014.11.015","type":"journal-article","created":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T02:49:05Z","timestamp":1417315745000},"page":"151-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hepatitis C infection is associated with hepatic toxicity but does not compromise the survival of patients with diffuse large B cell lymphoma treated with rituximab-based chemotherapy"],"prefix":"10.1016","volume":"39","author":[{"given":"Tzu-Ting","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Fang","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tse-Yen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Sargeant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Peng","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Min","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2014.11.015_bib0005","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/ijc.23416","article-title":"Hepatitis C infection and risk of malignant lymphoma","volume":"122","author":"Schollkopf","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.leukres.2014.11.015_bib0010","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2008.02.011","article-title":"Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium","volume":"6","author":"de Sanjose","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.leukres.2014.11.015_bib0015","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/hep.25499","article-title":"Hepatitis C and non-Hodgkin lymphoma: the clinical perspective","volume":"55","author":"Hartridge-Lambert","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.leukres.2014.11.015_bib0020","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1182\/blood-2002-10-3230","article-title":"Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case\u2013control study","volume":"102","author":"Mele","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.015_bib0025","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1349-7006.2004.tb03256.x","article-title":"Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies","volume":"95","author":"Matsuo","year":"2004","journal-title":"Cancer Sci"},{"key":"10.1016\/j.leukres.2014.11.015_bib0030","doi-asserted-by":"crossref","first-page":"e91373","DOI":"10.1371\/journal.pone.0091373","article-title":"B-cell-intrinsic hepatitis C virus expression leads to B-cell-lymphomagenesis and induction of NF-kappaB signalling","volume":"9","author":"Kasama","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.leukres.2014.11.015_bib0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/ajh.21564","article-title":"Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas","volume":"85","author":"Arcaini","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2014.11.015_bib0040","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2005.01.5016","article-title":"Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d\u2019Etude des Lymphomes de l\u2019Adulte programs","volume":"24","author":"Besson","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2014.11.015_bib0045","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1182\/blood-2010-06-289231","article-title":"Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis","volume":"116","author":"Ennishi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.015_bib0050","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3892\/or.2012.1883","article-title":"Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era: a single center experience","volume":"28","author":"Nishikawa","year":"2012","journal-title":"Oncol Rep"},{"key":"10.1016\/j.leukres.2014.11.015_bib0055","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/(SICI)1096-9071(199911)59:3<290::AID-JMV5>3.0.CO;2-R","article-title":"Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey","volume":"59","author":"Sun","year":"1999","journal-title":"J Med Virol"},{"issue":"Suppl. 2","key":"10.1016\/j.leukres.2014.11.015_bib0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1478-3231.2011.02540.x","article-title":"A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt","volume":"31","author":"Sievert","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.leukres.2014.11.015_bib0065","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1182\/blood-2006-08-041525","article-title":"Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease","volume":"109","author":"Lake-Bakaar","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.015_bib0070","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1179\/1607845413Y.0000000147","article-title":"Impact of treatment-related toxicity on outcome of HCV-positive diffuse large B-cell lymphoma in rituximab era","volume":"19","author":"Zaky","year":"2014","journal-title":"Hematology"},{"key":"10.1016\/j.leukres.2014.11.015_bib0075","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1224::AID-CNCR23>3.0.CO;2-6","article-title":"Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies","volume":"83","author":"Zuckerman","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2014.11.015_bib0080","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1172\/JCI67714","article-title":"Emerging concepts in immunity to hepatitis C virus infection","volume":"123","author":"Rosen","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2014.11.015_bib0085","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1172\/JCI39133","article-title":"Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence","volume":"119","author":"Rehermann","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2014.11.015_bib0090","doi-asserted-by":"crossref","first-page":"7896","DOI":"10.3748\/wjg.v19.i44.7896","article-title":"An insight into the diagnosis and pathogenesis of hepatitis C virus infection","volume":"19","author":"Irshad","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.leukres.2014.11.015_bib0095","first-page":"219","article-title":"Innate immune responses to hepatitis C virus","volume":"369","author":"Schoggins","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.leukres.2014.11.015_bib0100","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1200\/JCO.2012.48.5938","article-title":"Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B","volume":"31","author":"Huang","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2014.11.015_bib0105","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/hep.26718","article-title":"Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study","volume":"59","author":"Hsu","year":"2014","journal-title":"Hepatology"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212614003671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212614003671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T12:16:27Z","timestamp":1717589787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212614003671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0145212614003671"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2014.11.015","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C infection is associated with hepatic toxicity but does not compromise the survival of patients with diffuse large B cell lymphoma treated with rituximab-based chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2014.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}